To Be Discontinued Tablet Anti-Infective
Ethionamide Tablet · 422 days since initial FDA posting
FDA lists Ethionamide Tablet as To Be Discontinued (Pfizer Inc.).
No availability text on this FDA row.
Ethionamide Tablet: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Ethionamide Tablet
- Manufacturer
- Pfizer Inc.
- Dosage Form
- Tablet
- Presentation
- Trecator, Tablet, 250 mg (NDC 0008-4117-01)
- Package NDC
- 0008-4117-01
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Jul 16, 2025
- Last Updated
- Jul 16, 2025
- Therapeutic Category
- Anti-Infective
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug. Supply expected to exhaust September 2025
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.